Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Echinobase
ECB-ART-47461
Int J Mol Sci 2019 Sep 24;2019:. doi: 10.3390/ijms20194738.
Show Gene links Show Anatomy links

Holothuria Leucospilota Polysaccharides Ameliorate Hyperlipidemia in High-Fat Diet-Induced Rats via Short-Chain Fatty Acids Production and Lipid Metabolism Regulation.

Yuan Y , Liu Q , Zhao F , Cao J , Shen X , Li C .


???displayArticle.abstract???
Holothuria leucospilota polysaccharides (HLP) are expected to become potential resources for the treatment of hyperlipidemia because of their various bioactivities. In the study, the treatment of HLP on improving hyperlipidemia in rats was explored. Oral administration of HLP at 100 or 200 mg/kg body weight effectively alleviated serum lipid levels and liver histological abnormalities in high-fat-diet rats. HLP regulated abnormal mRNA, lipogenesis-related hormones and inflammatory cytokines (tumor necrosis factor-α, interleukin-6 and interleukin-12) levels. HLP improved the ability of gut microbiota to produce short-chain fatty acids (SCFAs). SCFAs have been found to ameliorate liver lesions. Therefore, HLP alleviated hyperlipidemia by improving the levels of SCFAs to regulate lipid metabolism. These results indicated that HLP could be used as beneficial polysaccharides to alleviate hyperlipidemia.

???displayArticle.pubmedLink??? 31554265
???displayArticle.pmcLink??? PMC6801986
???displayArticle.link??? Int J Mol Sci
???displayArticle.grants??? [+]

Genes referenced: fat4 LOC590500


???attribute.lit??? ???displayArticles.show???
References [+] :
Cao, Recent AHA/ACC guidelines on cholesterol management expands the role of the clinical laboratory. 2019, Pubmed